scholarly journals Evaluation of a Janus kinase 1 inhibitor, PF-04965842, in healthy subjects: A phase 1, randomized, placebo-controlled, dose-escalation study

2018 ◽  
Vol 84 (8) ◽  
pp. 1776-1788 ◽  
Author(s):  
Elena Peeva ◽  
Martin R. Hodge ◽  
Elizabeth Kieras ◽  
Michael L. Vazquez ◽  
Kosalaram Goteti ◽  
...  
Keyword(s):  
Dose Escalation ◽  
Healthy Subjects ◽  
Phase 1 ◽  
Janus Kinase ◽  
Dose Escalation Study ◽  
Janus Kinase 1

scholarly journals A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics

2012 ◽  
Vol 75 (1) ◽  
pp. 118-128 ◽  
Author(s):  
Peter Hodsman ◽  
Claire Ashman ◽  
Anthony Cahn ◽  
Erika De Boever ◽  
Nicholas Locantore ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Dose Escalation ◽  
Healthy Subjects ◽  
Phase 1 ◽  
Dose Escalation Study

scholarly journals Inhibition of Complement C3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results

2021 ◽  
Author(s):  
Charles C. Wykoff ◽  
Vrinda Hershberger ◽  
David Eichenbaum ◽  
Erin Henry ◽  
Husam S. Younis ◽  
...  
Keyword(s):  
Dose Escalation ◽  
Phase 1 ◽  
Geographic Atrophy ◽  
Complement C3 ◽  
Dose Escalation Study ◽  
Study Results
Sign in / Sign up

Export Citation Format

Share Document